COMP <GO>
DCGO vs BMGL // EV/EBITDA & P/E VALUATION
DocGo Inc. (NASDAQ) VS. Basel Medical Group Ltd (NASDAQ) • 15-METRIC TALLY: DCGO 0
— BMGL 2
■ METRIC PARITY
LAST: $0.27 (-2.43%) • MKT CAP: $27.0M
valuation
—
LAST: $4.75 (+3.26%) • MKT CAP: $36.0M
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (DCGO VS. BMGL)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | DCGO | BMGL | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | — | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -55.30% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | -60.00% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | -47.70% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | — | — | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 31.3 | 67.5 | -36.20 | BMGL | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $27.0M | $36.0M | -$9.0M | BMGL | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | DCGO REV | BMGL REV | DCGO GROSS % | BMGL GROSS % | DCGO FCF | BMGL FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $322.2M | — | — | — | $29.9M | — |
| FY 2024 | $616.6M | — | — | — | $66.5M | — |
| FY 2023 | $624.3M | — | — | — | -$64.5M | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
DCGO // BETA —
BMGL // BETA —